A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
Biotech royalty player Ligand Pharmaceuticals reported a notable insider sale following a year of strong stock performance.
A Ligand Pharmaceuticals (LGND) Insider Sold 5,000 Shares for $1.1 Million
Overview
Andrew Reardon, CLO & Secretary at Ligand (NASDAQ:LGND), reported the sale of 5,000 shares of Common Stock for approximately ~$1.14 million on June 1, 2026, following the immediate exercise and disposition of stock options under an SEC Form 4 filing: SEC Form 4 filing
Transaction value based on SEC Form 4 weighted average purchase price ($227.06); post-transaction value based on June 1, 2026 market close ($227.06).
Details
* 1-year price change calculated as of June 5, 2026.
Source
Originally published at www.fool.com.
Related Articles
- 51% of U.S. adults say the American Dream is out of reach for most people right now: CNBC survey
- A massive 16% market swing just rocked South Korea over 24 hours. The retail ‘ants’ holding the wheel are driving dangerously.
- I’m 60, retired with $3 million. My fiancée, 55, has $1 million but plans to work for the next 10 years. Are we compatible?
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.
